Search Results - "Ekenel, M"

Sunitinib versus pazopanib for patients with metastatic renal cell carcinoma: 2 Turkish hospital experience by Ekenel, M., Karabulut, S., Cil, I., Zırtıloglu, A., Aydın, E., Tural, D.

“…Sunitinib (SUN) and Pazopanib (PAZ) are two oral tyrosine kinase inhibitors (TKIs) against vascular endothelial growth factor (VEGF). Their efficacy and safety…”
Get full text

HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples by Gumus, M, Yumuk, P F, Salepci, T, Aliustaoglu, M, Dane, F, Ekenel, M, Basaran, G, Kaya, H, Barisik, N, Turhal, N S

“…Viruses are known to be associated with human malignancies, e.g., Epstein-Barr virus, human papillomavirus (HPV) and human T-cell leukemia virus type I. We…”
Get more information

Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC) by Keskin, S., Yıldız, I., Sen, F., Aydogan, F., Kilic, L., Ekenel, M., Saglam, S., Sakar, B., Disci, R., Aykan, F.

“…Purpose The aim of this retrospective study (from January 2007 to December 2011) was to investigate the efficacy and tolerability of mDCF schedule for…”
Get full text

Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma by Yildiz, I, Sen, F, Kilic, L, Ekenel, M, Ordu, C, Kilicaslan, I, Darendeliler, E, Tunc, H M, Varol, U, Bavbek, S, Basaran, M

“…We investigated the prognostic clinicopathologic factors associated with overall survival (os) and progression-free survival (pfs) in the once-daily continuous…”
Get full text

Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib by Sen, F, Yildiz, I, Basaran, M, Ekenel, M, Oz, F, Kilic, L, Toz, B, Gurdal, A, Camlica, H, Bavbek, S, Oflaz, H

“…Hypertension is one of the major side effects of sunitinib, an angiogenesis inhibitor used in the treatment of metastatic renal cell carcinomas (mRCC) and…”
Get more information

Does the Timing of Radiotherapy Impact Survival of Glioblastoma Multiforme Patients? by Tezcanli, E.K, Ucuncu, A, Sarihan, S, Aksu, A, Eroglu, C, Alco, G, Kamer, S, Ekenel, M, Aytac Arslan, S, Abacioglu, U

Get full text

The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients by Yumuk, P F, Aydin, S Z, Dane, F, Gumus, M, Ekenel, M, Aliustaoglu, M, Karamanoglu, A, Sengoz, M, Turhal, S N

Get full text

2502 ORAL Does initial response to corticosteroids predict survival in primary CNS lymphoma (PCNSL)? by Ekenel, M, Iwamoto, F.M, Ben Porat, L.S, DeAngelis, L.M, Abrey, L.E

Get full text

Induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT) in nasopharyngeal carcinoma (NPC) by Kaval, G., Altun, M., Ibis, K., Ozkaya, K., Meral, R., Karadeniz, A.N., Sarı, M., Ekenel, M., Basaran, M., Bavbek, S.

Get full text

1143P - Induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT) in nasopharyngeal carcinoma (NPC) by Kaval, G., Altun, M., Ibis, K., Ozkaya, K., Meral, R., Karadeniz, A.N., Sarı, M., Ekenel, M., Basaran, M., Bavbek, S.

“…Current treatment of locoregionally advanced NPC (LRA-NPC) is CCRT with or without adjuvant chemotherapy (CT). The value of adding IC to CCRT in LRA-NPC is…”
Get full text

Scleredema of Buschke associated with Waldenström's macroglobulinaemia by Ratip, S., Akin, H., Özdemirli, M., Yücelten, D., Kuş, S., Ekenel, M., Bayik, M.

Get full text

Remitting seronegative symmetrical synovitis with pitting oedema associated with chronic lymphocytic leukaemia by Ekenel, M, Yavuz, S, Karti, S, Direskeneli, H, Akoğlu, T

“…We describe a case of remitting seronegative symmetrical synovitis with pitting oedema (RS3PE syndrome) in a 67-year-old man. Immunophenotyping studies and…”
Get full text

Sunitinib versus pazopanib for patients with metastatic renal cell carcinoma: Two Turkish hospital experience, a retrospective comparative case series study by Ekenel, M., Aydin, E., Cil, I., Zirtiloglu, A., Tural, D., Karabulut, S.

Get full text

1143PInduction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT) in nasopharyngeal carcinoma (NPC) by Kaval, G, Altun, M, Ibis, K, Ozkaya, K, Meral, R, Karadeniz, A N, Sarı, M, Ekenel, M, Basaran, M, Bavbek, S

“…Abstract Background Current treatment of locoregionally advanced NPC (LRA-NPC) is CCRT with or without adjuvant chemotherapy (CT). The value of adding IC to…”
Get full text

781P Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab by Tural, D., Ölmez, Ö.F., Sümbül, A.T., Özhan, N., Akar, E., Çakar, B., Köstek, O., Ekenel, M., Erman, M., Çoşkun, H.Ş., Selçukbiricik, F., Keskin, O., Paksoy, F., Oruç, K., S. Bayram, Yılmaz, U., Bilgetekin, I., Yıldız, B., Şendur, M.A.N., Artac, M.

Get full text

Durability performance of RC beams strengthened with epoxy injection and CFRP fabrics by Ekenel, Mahmut, Myers, John J.

“…Cracks in reinforced concrete (RC) should be repaired if they present the potential for durability related problems such as corrosion of reinforcing steel. One…”
Get full text

Comparison of two different adjuvant treatment approaches for patients with locally advanced gastric cancer by Ekenel, M., Ozer, L., Ordu, C., Saglam, E. K., Kizir, A., Oral, E. N., Aykan, N. F.

“…Abstract only…”
Get full text

Surveillance results of patients with stage I nonseminomatous testis cancer by Keskin, S., Ekenel, M., Başaran, M., Esen, T., Özcan, F., Tunç, M., Bavbek, S. E.

“…Abstract only…”
Get full text

Clinical outcomes in patients with locally advanced nasopharyngeal cancer treated with neoadjuvant docetaxel and cisplatin followed by radiation treatment and concomitant cisplatin by Ekenel, M., Keskin, S., Başsaran, M., Bavbek, S. E., Ozdemir, C., Meral, R., Altun, M.

“…Abstract only…”
Get full text

Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey by Yildiz, Ibrahim, Sen, Fatma, Basaran, Mert, Ekenel, Meltem, Agaoglu, Fulya, Darendeliler, Emin, Tunc, Hayri Murat, Ozcan, Faruk, Bavbek, Sevil

“…Objective Therapy targeted against the vascular endothelial growth factor pathway is a standard of care for patients with metastatic renal cell carcinoma. This…”
Get full text